Drug history and remote exposure to drugs. A cause of lung disease?

European Respiratory Journal

Volumn 16, Issue 3, 2000, Pages 381-384

  Camus, P ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DOSULEPIN; FUROSEMIDE; IMIPRAMINE; NITROFURANTOIN; NITROSOUREA DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANAPHYLAXIS; BRONCHIOLITIS; BRONCHOSPASM; DISEASE MARKER; DISEASE SEVERITY; DRUG EXPOSURE; EDITORIAL; ENVIRONMENTAL FACTOR; FIBROSING ALVEOLITIS; HYPERTENSION; LUNG FIBROSIS; MENTAL STRESS; OCCUPATION; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RADIATION EXPOSURE; STATISTICS;

ADULT; ANTIDEPRESSIVE AGENTS; HUMAN; PULMONARY FIBROSIS;

EID: 0033805813     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.016003381.x     Document Type: Editorial

References (65)

1. Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: A case-control study
2. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis
3. Mortality rates from cryptogenic fibrosing alveolitis in seven countries
4. Survival in patients with cryptogenic fibrosing alveolitis: A population-based cohort study
5. Lung cancer and cryptogenic fibrosing alveolitis - A population-based cohort study
6. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
7. Cryptogenic fibrosing alveolitis
8. Drug-induced asthma
9. Angioodem unter ACE-Hemmern and Angiotensin-II-receptor-Antagonisten: Analyse von 98 Fallen
10. Amiodarone-induced pulmonary toxicity
11. Delayed methotrexate pneumonitis
12. Late pulmonary toxicity of bleomycin
13. Interstitial pneumonia 2 months after discontinuing amiodarone
14. Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol - A case report
15. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease
16. Late pulmonary toxicity after treatment for Hodgkin's disease
17. Restrictive lung disease following treatment for malignant brain tumors: A potential late effect of craniospinal irradiation
18. Radiation pneumonitis caused by yttrium-90 microspheres: Radiologic findings
19. Delayed pulmonary fibrosis after nitrosourea therapy
20. Late-effect after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin
21. Lung toxicity associated with cyclophosphamide use. Two distinct patterns
22. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer
23. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood
24. Pulmonary hypertension, 'plexogenic pulmonary arteriopathy' and the appetite depressant drug aminorex: Post or propter?
25. Appetite suppressants and pulmonary hypertension
26. Primary pulmonary hypertension associated with the use of fenfluramine derivatives
27. Epidemics of vascular toxicity and pulmonary hypertension: What can be learned?
28. Bronchiolitis obliterans following the ingestion of an Asian shrub leaf
29. Pleuropulmonary changes induced by ergoline drugs
30. Development of severe adverse effects after discontinuing amiodarone therapy in human heart transplant recipients
31. Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug. A case report and review of the literature
32. Pharmacokinetics of amiodarone in the isolated rat lung
33. Lung as reservoir for antidepressants in pharmacokinetic drug interactions
34. Loeffler's syndrome: An uncommon adverse reaction to imipramine
35. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment
36. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone
37. Amiodarone and the development of ARDS after lung surgery
38. Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment
39. Minocycline pneumonitis and eosinophilia: A report on 8 patients
40. D-penicillamine-induced severe pneumonitis
41. Interferon-related bronchiolitis obliterans organizing pneumonia
42. Sarcoidosis and IFN-alpha treatment
43. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors
44. Idiopathic pneumonia syndrome after high dose chemotherapy for relapsed Hodgkin's disease
45. Idiopathic pneumonia syndrome - Changing spectrum of lung injury after marrow transplantation
46. Drugs that may injure the respiratory system
47. Nilutamide pneumonitis: A report on eight patients
48. Halothane hepatitis in a South African population. Frequency and the influence of gender and ethnicity
49. A case of pneumonitis due to Rikkunshi-to
50. Pneumonitis due to Hangeshashin-to
51. The role of plant-derived drugs and herbal medicines in healthcare
52. Lung injury related to consuming Sauropus androgynus vegetable
53. Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan
54. Harmless herbs? A review of the recent literature
55. Drug-related myocarditis. I. Hypersensitivity myocarditis
56. Hypersensitivity myocarditis and hepatitis associated with imipramine and its metabolite desipramine
57. Eosinophilic myocarditis associated with toxicodermia caused by phenobarbital
58. Hypersensitivity myocarditis associated with ephedra use
59. Valvular heart disease associated with fenfluramine-phentermine
60. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo
61. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
62. Echocardiographic improvement overt time after cessation of use of fenfluramine and phentermine
63. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis
64. Immunotoxicology of the liver: Adverse reactions to drugs